Mitochondrial function in response to cardiac ischemia-reperfusion after oral treatment with quercetin

Free Radical Biology and Medicine

Volumn 32, Issue 11, 2002, Pages 1220-1228

  Brookes, Paul S ^a,e   Digerness, Stanley B ^b   Parks, Dale A ^c,d,e   Darley Usmar, Victor ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Free radicals; Mitochondria; Myocardial ischemia reperfusion; Polyphenols; Quercetin; Red wine

Indexed keywords

QUERCETIN; ANTIOXIDANT; CARDIOTONIC AGENT; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VITRO STUDY; MALE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; WINE; ANIMAL; HEART; HEART MITOCHONDRION; HEART MUSCLE; METABOLISM; ORAL DRUG ADMINISTRATION; OXYGEN CONSUMPTION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMAL; ANTIOXIDANTS; CARDIOTONIC AGENTS; HEART; MALE; MITOCHONDRIA, HEART; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXYGEN CONSUMPTION; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS;

EID: 0036591865     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)00839-0     Document Type: Article

References (48)

1. Absorption and excretion of conjugated flavonols, including quercetin-4′-O-beta-glucoside and isorhamnetin-4′-O-beta-glucoside by human volunteers after the consumption of onions
2. (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine
3. Alcohol, ischemic heart disease, and the French paradox
4. Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake
5. Review of the biology of Quercetin and related bioflavonoids
6. Absorption and disposition kinetics of the dietary antioxidant quercetin in man
7. Flavonoids in food and natural antioxidants in wine
8. Wine as a biological fluid: History, production, and role in disease prevention
9. The bioavailability of non-nutrient plant factors: Dietary flavonoids and phyto-oestrogens
10. Antioxidants in food and chronic degenerative diseases
11. Interaction of dietary antioxidants in vivo: How fruit and vegetables prevent disease?
12. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study
13. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study
14. Flavonoid intake and coronary mortality in Finland: A cohort study [see comments]
15. Serum cholesterol in cross-cultural perspective. The Seven Countries Study
16. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals
17. Moderate alcohol consumption: The gentle face of Janus
18. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects
19. Alcohol-free red wine enhances plasma antioxidant capacity in humans
20. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease
21. Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA
22. Pig heart mitochondrial ATPase: Properties of purified and membrane-bound enzyme. Effects of flavonoids
23. Bioflavonoid regulation of ATPase and hexokinase activity in Ehrlich ascites cell mitochondria
24. Inhibition of mitochondrial respiration and cyanide-stimulated generation of reactive oxygen species by selected flavonoids
25. Effect of quercetin on membrane-linked activities
26. Effect of naturally occurring flavonoids on lipid peroxidation and membrane permeability transition in mitochondria
27. Bioavailability of flavonoids and potential bioactive forms in vivo
28. Changes in mitochondrial matrix free calcium in perfused rat hearts subjected to hypoxia-reoxygenation
29. Oxygen and reperfusion damage: An overview
30. Peroxynitrite irreversibly decreases diastolic and systolic function in cardiac muscle
31. Hypoxia-reoxygenation induced increase in cellular Ca2+ in myocytes and perfused hearts: The role of mitochondria
32. Stimulation of mitochondrial oxygen consumption in isolated cardiomyocytes after hypoxia-reoxygenation
33. Early alteration of the control of mitochondrial function in myocardial ischemia
34. On the regulation of cellular energetics in health and disease
35. From calcium signaling to cell death: Two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state
36. The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy
37. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle
38. Protein measurement with the Folin phenol reagent
39. Citrate synthase from rat liver
40. The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen
41. Chlorination and nitration of soy isoflavones
42. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice
43. Invited review: Manganese superoxide dismutase in disease
44. Activation of NFkappaB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells
45. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product
46. Bioavailability and health effects of dietary flavonols in man
47. Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man
48. Quercetin abrogates taxol-mediated signaling by inhibiting multiple kinases